Envista Holdings Corp
NVST29.100USD
+4.380+17.73%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
4.77BCap. mercado
104.02P/E TTM
Más Datos de Envista Holdings Corp Compañía
Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Información de Envista Holdings Corp
Símbolo de cotizaciónNVST
Nombre de la empresaEnvista Holdings Corp
Fecha de salida a bolsaSep 18, 2019
Director ejecutivoKeel (Paul A)
Número de empleados12300
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 18
Dirección200 S. Kraemer Blvd., Bldg. E
CiudadBREA
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal92821
Teléfono17148175418
Sitio Webhttps://envistaco.com/en
Símbolo de cotizaciónNVST
Fecha de salida a bolsaSep 18, 2019
Director ejecutivoKeel (Paul A)
Ejecutivos de Envista Holdings Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-804.00%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+10450.00%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+10450.00%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-5422.00%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+10450.00%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+10450.00%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
41.98K
-1771.00%
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
33.32K
-54097.00%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
54.94K
-804.00%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+10450.00%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+10450.00%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
50.32K
-5422.00%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+10450.00%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+10450.00%
Desglose de ingresos
Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
Northern America
348.10M
51.96%
Emerging markets
152.00M
22.69%
Western Europe
139.10M
20.76%
Other developed markets
30.70M
4.58%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.79%
BlackRock Institutional Trust Company, N.A.
8.74%
Ariel Investments, LLC
7.33%
Dimensional Fund Advisors, L.P.
5.82%
Atlanta Capital Management Company, L.L.C.
5.29%
Otro
63.03%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
9.79%
BlackRock Institutional Trust Company, N.A.
8.74%
Ariel Investments, LLC
7.33%
Dimensional Fund Advisors, L.P.
5.82%
Atlanta Capital Management Company, L.L.C.
5.29%
Otro
63.03%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.18%
Investment Advisor/Hedge Fund
47.53%
Hedge Fund
10.51%
Research Firm
1.57%
Pension Fund
1.40%
Sovereign Wealth Fund
1.39%
Bank and Trust
0.53%
Individual Investor
0.52%
Private Equity
0.41%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
695
191.29M
116.34%
-29.84M
2025Q3
713
196.49M
119.50%
-31.47M
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
16.33M
9.93%
-591.98K
-3.50%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
14.32M
8.71%
-376.73K
-2.56%
Sep 30, 2025
Ariel Investments, LLC
12.00M
7.3%
-351.46K
-2.84%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
9.54M
5.8%
+367.36K
+4.01%
Sep 30, 2025
Atlanta Capital Management Company, L.L.C.
8.67M
5.27%
-2.15M
-19.86%
Sep 30, 2025
Franklin Mutual Advisers, LLC
8.69M
5.29%
-262.48K
-2.93%
Sep 30, 2025
Harris Associates L.P.
6.85M
4.17%
-962.59K
-12.32%
Sep 30, 2025
Gates Capital Management, Inc.
6.22M
3.78%
-105.21K
-1.66%
Sep 30, 2025
AllianceBernstein L.P.
6.10M
3.71%
+235.00
+0.00%
Sep 30, 2025
Victory Capital Management Inc.
5.91M
3.59%
+160.19K
+2.79%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
State Street SPDR S&P Health Care Equipment ETF
1.75%
Schwab Ariel Opportunities ETF
1.51%
Pacer US Export Leaders ETF
0.88%
Distillate Small/Mid Cash Flow ETF
0.58%
Royce Quant Small-Cap Quality Value ETF
0.5%
Harbor Long-Short Equity ETF
0.45%
First Trust Health Care Alphadex Fund
0.41%
iShares U.S. Medical Devices ETF
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
DFA Dimensional US Small Cap Value ETF
0.27%
Ver más
State Street SPDR S&P Health Care Equipment ETF
Proporción1.75%
Schwab Ariel Opportunities ETF
Proporción1.51%
Pacer US Export Leaders ETF
Proporción0.88%
Distillate Small/Mid Cash Flow ETF
Proporción0.58%
Royce Quant Small-Cap Quality Value ETF
Proporción0.5%
Harbor Long-Short Equity ETF
Proporción0.45%
First Trust Health Care Alphadex Fund
Proporción0.41%
iShares U.S. Medical Devices ETF
Proporción0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporción0.3%
DFA Dimensional US Small Cap Value ETF
Proporción0.27%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
